Prism 9

Manufactured by GraphPad

Visit Supplier

Sourced in United States, Austria, Germany, United Kingdom, Belgium, Canada, China, Japan, Poland, Lao People's Democratic Republic, France, Switzerland, Ireland, Spain, Sweden

About the product

Prism 9 is a powerful data analysis and graphing software developed by GraphPad. It provides a suite of tools for organizing, analyzing, and visualizing scientific data. Prism 9 offers a range of analysis methods, including curve fitting, statistical tests, and data transformation, to help researchers and scientists interpret their data effectively.

Automatically generated - may contain errors

Get Technical Specifications Find protocols

Lab products found in correlation

Spss 26, by IBM (234 mentions) Spss statistics 26, by IBM (113 mentions) Spss 25, by IBM (111 mentions) Spss version 26, by IBM (91 mentions) Spss 22, by IBM (91 mentions) Spss 27, by IBM (72 mentions) Spss statistics 25, by IBM (71 mentions) Spss statistic, by IBM (70 mentions) Spss statistics 27, by IBM (66 mentions) Spss 23, by IBM (62 mentions) Prism 8, by GraphPad (56 mentions) Spss 20, by IBM (54 mentions) Spss version 25, by IBM (51 mentions) Clampfit 10, by Molecular Devices (47 mentions) Spss 28, by IBM (45 mentions) Spss 21, by IBM (41 mentions) Spss statistics 28, by IBM (38 mentions) Spss 24, by IBM (37 mentions) Trizol reagent, by Thermo Fisher Scientific (35 mentions) Spss version 22, by IBM (34 mentions)

Check compatibility

Market Availability & Pricing

GraphPad Prism 9 is commercially available through authorized distributors. GraphPad offers various subscription plans, including Personal, Group, and Enterprise options, which provide enhanced features and collaboration capabilities.

The pricing for GraphPad Prism 9 varies based on the subscription plan and user category:

- Personal Subscription:
- Annual Student: $142 per year
- Annual Corporate: $480 per year
- Annual Academic: $250 per year
- Monthly Subscription: $50 per month

- Group Subscription:
- Corporate:
- 2 seats: $1,040 per year
- 5 seats: $2,600 per year
- 10 seats: $5,200 per year
- Academic:
- 2 seats: $500 per year
- 5 seats: $1,250 per year
- 10 seats: $2,500 per year

- Enterprise Subscription: Custom pricing

Please note that pricing and subscription options are subject to change. Refer to GraphPad's official website for the most up-to-date information.

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

Spelling variants (same manufacturer)

Prism 9 for macOS - 136 citations Prism 8 or 9 - 20 citations GraphPad Prism 9.1.0 (221) - 11 citations GraphPad Prism 9.1.2 for Windows - 7 citations GraphPad Prism v8/9 - 6 citations Prisms 9 - 4 citations Prism 6-9 - 4 citations Prism 9.4.1 for Mac - 4 citations GraphPad Prism 9.5.1 for MacOS - 3 citations Prisms version 9.0 - 2 citations

Similar products (other manufacturers)

Prism 9.0 (by R Project for Statistical Computing) - 24 citations Graphad Prism 9.0 (by Graphad) - 10 citations Prism Grappad 9.0 (by GrapPad) - 7 citations Prism 9 (by Thermo Fisher Scientific) - 5 citations Prism 9 (by MedCalc) - 4 citations Prism 9.4.1 (by Jamovi) - 4 citations Prism GrapdPad 9.0 (by GrapdPad) - 3 citations Prism 9 (by Sangerbox) - 3 citations Prism 9.5.0 (by Corel) - 2 citations Prism 9 (by Scanpy) - 2 citations

The spelling variants listed below correspond to different ways the product may be referred to in scientific literature.
These variants have been automatically detected by our extraction engine, which groups similar formulations based on semantic similarity.

42 822 protocols using «prism 9»

Comparative Gene Expression Analysis

2025

The original data were imported into Microsoft Office Excel 2019 software. The quantitative expression was calculated using the 2^-ΔΔCT method. SPSS 22.0 software was used to perform an independent sample t-test to analyze the differences between the two groups, with p < 0.05 considered statistically significant. Graphpad Prism 9 was used for drawing.

Wang Z., Yang C., Dong B., Chen A., Song Q., Bai H., Jiang Y., Chang G, & Chen G. (2025). Whole Transcriptome Sequencing Reveals miRNAs and ceRNA Networks in Duck Abdominal Fat Deposition. Animals : an Open Access Journal from MDPI, 15(4), 506.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Statistical Analysis of Experimental Data

2025

The statistical analyses were performed using student's t-test or one-way analysis of variance (ANOVA) test by GraphPad Prism 9.0.0. Differences were considered statistically significant at *P < 0.05.

Liu T., Fu J., Zheng Z., Chen M., Wang W., Wu C., Quan G, & Pan X. (2025). Active microneedle patch equipped with spontaneous bubble generation for enhanced rheumatoid arthritis treatment. Theranostics, 15(8), 3424-3438.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Statistical Analysis and OPLS-DA of Biomedical Data

2025

SPSS 22.0 and GraphPad Prism 9 were used for statistical analysis. The measurement data of normal distribution were expressed as mean ± standard deviation (

\bar{x}

± s), and a t-test was used for inter-group comparison. The measurement data of non-normal distribution were expressed as median (quartile), and Mann–Whitney U test was used for comparison between groups. The chi-square test was used to compare the data groups. SIMCA was utilized for data analysis, employing orthogonal partial least squares discriminant analysis (OPLS-DA). The MedCalc software (MedCalc Software Ltd., Ostend, Belgium) was employed to calculate the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity. To assess the utility of GPR for assisted decision-making at various threshold probabilities, decision curve analysis (DCA) was used. A p < 0.05 was considered statistically different.

Zhu S., Yuan J., Ju F., Gu M., Xiang Z, & Zhang Y. (2025). The gamma-glutamyl transpeptidase to platelet ratio: a good noninvasive biomarker for predicting for the occurrence and prognosis of patients with hepatitis E virus-related acute liver failure. Frontiers in Medicine, 12, 1573114.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Statistical Analysis of R. aeschlimannii Growth Curves

2025

Data processing of the growth curves of two R. aeschlimannii strains was performed using GraphPad version Prism 9.0.0 software for statistical analysis (Figure 3A). Data were presented as mean ± SD (shown as error bars) at each time point and were analyzed for statistical significance by the two-sided Student’s t test to compare two independent groups.

Wang N., Ye R.Z., Yu H.J., Han X.Y., Tian D., Gao W.Y., Wang B.H., Du L.F., Zhang M.Z., Shi X.Y., Zhu D.Y., Shi W., Jia N., Jiang J.F., Sun Y., Zhao L., Cui X.M., Liu Z.H, & Cao W.C. (2025). Genomic characteristics of emerging human pathogen Rickettsia aeschlimannii isolated from two Hyalomma tick species. iScience, 28(3), 112080.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Comparative Statistical Analysis of Experimental Data

2025

All experimental data were presented as mean ± standard deviation (SD) and were analyzed using GraphPad Prism 9.0.0 software. To estimate differences between the two groups, a two-tailed unpaired Student’s t-test was employed. For multi-group comparisons, a one-way analysis of variance (ANOVA) with the Bonferroni post-hoc analysis was conducted. A p-value less than 0.05 was deemed statistically significant, indicating a meaningful difference among compared groups. The number of biological replicates is denoted by n, as specified in the corresponding figure legends.

Ge W., Zhang X., Lin J., Wang Y., Zhang X., Duan Y., Dai X., Zhang J., Zhang Y., Jiang M., Qiang H., Zhao Z., Zhang X, & Sun D. (2025). Rnd3 protects against doxorubicin-induced cardiotoxicity through inhibition of PANoptosis in a Rock1/Drp1/mitochondrial fission-dependent manner. Cell Death & Disease, 16(1), 2.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!